1. Cannabidiol and the corticoraphe circuit in post-traumatic stress disorder
- Author
-
Maryam S. Vasefi and Claire Alexander
- Subjects
CBD, Cannabidiol ,GPCRs, G-Protein Coupled Receptors ,PET, Positron Emission Tomography ,DRN, Dorsal Raphe Nucleus ,CB2R, Cannabinoid Receptor Type 2 ,Cannabidiol ,Traumatic Stress ,Prefrontal cortex ,5-HT, Serotonin ,General Neuroscience ,5-HT2AR, 5-HT Receptor Type 2 A ,Glutamate receptor ,PTSD ,PFC, Prefrontal Cortex ,ERK1/2, Extracellular Signal-Related Kinases Type 1 or Type 2 ,medicine.anatomical_structure ,GABAergic ,NMDAR, N-Methyl-D-aspartate Receptors ,CB1R, Cannabinoid Receptor Type 1 ,psychological phenomena and processes ,medicine.drug ,RC321-571 ,mPFC, Medial Prefrontal Cortex ,Serotonin ,Neurosciences. Biological psychiatry. Neuropsychiatry ,SSNRI, Selective Norepinephrine Reuptake Inhibitor ,Amygdala ,behavioral disciplines and activities ,Article ,Dorsal raphe nucleus ,2-AG, 2-arachidonoylglycerol ,medicine ,fMRI, Functional Magnetic Resonance Imaging ,SSRI, Selective Serotonin Reuptake Inhibitor ,PFC, DRN and Raphe ,business.industry ,PTSD, Post-Traumatic Stress Disorder ,GABA, Gamma-Aminobutyric Acid ,medicine.disease ,COVID-19, SARS-CoV-2 ,digestive system diseases ,AEA, Anandamide ,nervous system ,Extinction (neurology) ,5-HT1AR, 5-HT Receptor Type 1A ,TRPV1, Transient Receptor Potential Vanilloid 1 Channels ,business ,Hypoactivity ,Neuroscience ,FAAH, Fatty Acid Amide Hydrolase - Abstract
Post-Traumatic Stress Disorder (PTSD), characterized by re-experiencing, avoidance, negative affect, and impaired memory processing, may develop after traumatic events. PTSD is complicated by impaired plasticity and medial prefrontal cortex (mPFC) activity, hyperactivity of the amygdala, and impaired fear extinction. Cannabidiol (CBD) is a promising candidate for treatment due to its multimodal action that enhances plasticity and calms hyperexcitability. CBD’s mechanism in the mPFC of PTSD patients has been explored extensively, but literature on the mechanism in the dorsal raphe nucleus (DRN) is lacking. Following the PRISMA guidelines, we examined current literature regarding CBD in PTSD and overlapping symptomologies to propose a mechanism by which CBD treats PTSD via corticoraphe circuit. Acute CBD inhibits excess 5-HT release from DRN to amygdala and releases anandamide (AEA) onto amygdala inputs. By first reducing amygdala and DRN hyperactivity, CBD begins to ameliorate activity disparity between mPFC and amygdala. Chronic CBD recruits the mPFC, creating harmonious corticoraphe signaling. DRN releases enough 5-HT to ameliorate mPFC hypoactivity, while the mPFC continuously excites DRN 5-HT neurons via glutamate. Meanwhile, AEA regulates corticoraphe activity to stabilize signaling. AEA prevents DRN GABAergic interneurons from inhibiting 5-HT release so the DRN can assist the mPFC in overcoming its hypoactivity. DRN-mediated restoration of mPFC activity underlies CBD’s mechanism on fear extinction and learning of stress coping., Highlights • CBD reduces PTSD symptoms via the DRN and corticoraphe circuit. • Acute effects of CBD reduce DRN-amygdala excitatory signaling to lessen the activity disparity between amygdala and mPFC. • Chronic CBD officially resolves mPFC hypoactivity by facilitating 5-HT release from DRN to mPFC. • CBD-facilitated endocannabinoid signaling stabilizes DRN activity and restores mPFC inhibitory control. • Chronically administered CBD acts via the corticoraphe circuit to favor fear extinction over fear memory reconsolidation.
- Published
- 2021